Identification of highly expressed genes in metastasis-suppressed chromosome 6/human malignant melanoma hybrid cells using subtractive hybridization and differential display

International Journal of Cancer

Volumn 71, Issue 6, 1997, Pages 1035-1044

  Lee, Jeong Hyung ^a   Welch, Danny R ^a  

^a PENN STATE CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA;

ARTICLE; CHROMOSOME 6; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HYBRID CELL; HYBRIDIZATION; MELANOMA CELL; METASTASIS INHIBITION; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; BASE SEQUENCE; CHROMOSOMES, HUMAN, PAIR 6; CLONING, MOLECULAR; DNA, COMPLEMENTARY; GENE EXPRESSION; GENES, TUMOR SUPPRESSOR; HUMANS; HYBRID CELLS; MELANOMA; MOLECULAR SEQUENCE DATA; NEOPLASM METASTASIS; NUCLEAR PROTEINS; NUCLEIC ACID HYBRIDIZATION; TUMOR CELLS, CULTURED;

EID: 0030993620     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970611)71:6<1035::AID-IJC20>3.0.CO;2-B     Document Type: Article

References (59)

1. BALCH, C.M., HOUGHTON, A.N., MILTON, G.W., SOBER, A.J. and SONG, S.J., Cutaneous melanoma, J.B. Lippincott, Philadelphia (1992).
2. BEHRENS, J., LOWRICK, O., KLEIN-HITPASS, L. and BIRCHMEIER, W., The E-cadherin promoter: functional analysis of a G:C rich region and an epithelial cell-specific palindromic regulatory element. Proc. nat. Acad. Sci. (Wash.), 88, 11495-11499 (1991).
3. BOSHER, J.M., WILLIAMS, T. and HURST, H.C., The developmentally regulated transcription factor AP2 is involved in c-erbB2 overexpression in human mammary carcinoma. Proc. nat. Acad. Sci. (Wash.), 92, 744-747 (1995).
4. BUSSEMAKERS, M.J.G., VAN DE VEN, W.J.M., DEBRUYNE, F.M.J. and SCHALKEN, J.A., Identification of a high mobility group protein I(Y) as potential progression marker for prostate cancer by differential hybridization analysis. Cancer Res., 51, 606-611 (1991).
5. CHAN, P.-K., CHAN, W.-Y., YUNG, B.Y.M., COOK, R.G., ALDRICH, M.G., KU, D., GLDKNOPF, I.L. and BUSCH, H., Amino acid sequences of a specific antigenic peptide of protein B23. J. biol. Chem., 261, 14355-14341 (1986).
6. CHANG, J.H. and OLSON, M.O., A single gene codes for two forms of rat nucleolar protein B23 mRNA. J. biol. Chem., 264, 11732-11737 (1989).
7. CHIAPPETTA, G., BANDIERA, A., BERLINGIERI, M.T., VISCONTI, R., MANFIOLETTI, G., BATTISTA, S., MARTINEZ-TELLO, F.J., SANTORO, M., GIANCOTTI, V. and FUSCO, A., The expression of the high mobility group HMGI (Y) proteins correlates with the malignant phenotype of human thyroid neoplasias. Oncogene. 10, 1307-1314 (1995).
8. DEAR, T.N. and KEFFORD, R.F. Molecular oncogenetics of metastasis. Mol. Aspects Med., 11, 243-324 (1990).
9. DEAR, T.N., RAMSHAW, I.A. and KEFFORD, R.F., Differential expression of a novel gene. WDNM1, in nonmetastatie rat mammary adenocarcinoma cells. Cancer Res., 48, 5203-5209 (1988).
10. DEGEN, W.G.J., WETERMAN, M.A.J., VAN GRONINGEN, J.J.M., CORNELISSEN, I.M.A.H., LEMMERS, J.P.W.M., AGTERBOS, M.A., VAN KESSEL, A.G., SWART, G.W.M. and BLOEMERS, H.P.J., Expression of nma, a novel gene, inversely correlates with the metastati potential of human melanoma cell lines and xenografts, Int. J. Cancer, 65, 460-465 (1996).
11. Du, W., THANOS, D. and MANIATIS, T., Mechanisms of transcriptional synergism between distinct virus-inducible enhancer elements. Cell 74, 887-898 (1993).
12. DUAN, C. and CLEMMONS, D.R., Transcription factor AP-2 regulates human insulin-like growth factor binding protein-5 gene expression. J. biol. Chew., 270, 24844-24851 (1995).
13. EBRALIDZE, A., TULCHINSKY, E.M., GRIGORIAN, M.S., AFANASYEVA, A., SENIN, V., REVANZOVA, E. and LUKANIDIN, E., Isolation and characterization of a gene specifically expressed in different metastatic cells and whose deduced gene product has a high degree of homology to a calcium-binding protein family. Gene Develop., 3, 1086-1093 (1989).
14. ECKNER, R. and BIRNSTIEL, M.L., Cloning of cDNAs for human HMG-I and HMG-Y proteins: both are capable of binding the octamer sequence motif. Nucleic Acids Res., 17, 5947-5959 (1989).
15. FEDELE, M., BANDIERA, A., CHIAPPETTA, G., BATTISTA, S., VIGLIETTO, G., MANFIOLETTI, G., CASAMASSIMI, A., SANTORO, M., GIANCOTTI, V. and FLISCO, A., Human colorectal carcinomas express high levels of high mobility group HMGI(Y) proteins. Cancer Res., 56, 1896-1901 (1996).
16. FIDLER, I.J., Critical factors in the biology of human cancer metastasis. Cancer Res., 50, 6130-6138 (1990).
17. FRIEDMANN, M., HOLTH, L.T., ZOGHBI, H.Y. and REEVES, R., Organization, inducible-expression and chromosome localization of the human HMGI(Y) nonhistone protein gene. Nucleic Adds Res., 21, 4259-4267 (1993).
18. GAYNOR, R.B., MUCHARDT, C., XIA, Y.R., KLISAK, I., MOHANDAS, T.K., SPARKES, R.S. and LUSIS, A.J., Localization of the gene for the DNA binding protein AP2 to human chromosome 6p22.3-pter. Genomics. 10, 1100-1102 (1991).
19. GRAEVEN, U. and HERLYN, M., In vitro growth patterns of normal human melanocytes and melanocytes from different stages of melanoma progression. J. Immunother., 12, 199-202 (1992).
20. GUALANDI, F. MORELLI, C., PAVAN, J.V., RIMESSI, P., SENSI, A., BONFATTI, A., GRUPPIONI, R., POSSATI, L., STANBRIDGE, E.J. and BARBANTI-BRODANO, G., Induction of senescence and control of tumorigenicity in BK virus transformed mouse cells by human chromosome 6. Genes Chromosomes Cancer, 10, 77-84 (1994).
21. HENNIG, G., LOWRICK, O., BIRCHMEIER, W. and BEHRENS, J., Mechanisms identified in the transcriptional control of epithelial gene expression. J. biol. Chem., 271, 595-602 (1996).
22. HERLYN, M., THURIN, J., BALABAN, G., BENNIELLI, J.L., HERLYN, D., ELDER. D.E., BONDI, E., GUERRY, D.P. NOWELL, P., CLARK, W.H. and KOPROWSKI, H., Characteristics of cultured human melanocytes isolated from different stages of tumor progression. Cancer Res., 45, 5670-5676 (1985).
23. INOUYE, C.J. and SETO, E., Relief of YY1 -induced transcriptional repression by protein-protein interaction with the nucleolar phosphoprotein B23. J. biol. Chem., 269, 6506-6510 (1994).
24. ISHIGURO, T., NAKAJIMA, M., NAITO, M., Muro, T. and TSURUO, T., Identification of genes differentially expressed in B16 murine melanoma sublines with different metastatic potentials. Cancer Res., 56, 875-879 (1996).
25. ISHIKAWA, M., DENNIS, J.W., MAN, S. and KERBEL, R.S., Isolation and characterization of spontaneous wheat germ agglutinin-resistant human melanoma mulams displaying remarkably different metastatic profiles in nude mice. Cancer Res., 48, 665-670 (1988a).
26. ISHIKAWA, M., FERNANDEZ, B. and KERBEL, R.S., Highly pigmented human melimoma variants which metastasizes widely in nude mice, including to skin and brain. Cancer Res., 48, 4897-4903 (1988b).
27. JIANG, H., LIN, J. and FISHER, P.B., A molecular definition of terminal cell differentiation in human melanoma cells. Mol. Cell Differentiation, 2, 221-239 (1994).
28. JIANG, H., LIN, J., Su, Z., HERLYN, M., KERBEL, R.S., WEISSMAN, B.E., WELCH, D.R. and FISHER, P.B., The melanoma differentiation-associated gene mda-6, which encodes the cyclin-dependent kinase inhibitor p2l. is differentially expressed during growth, differentiation and progression in human melanoma cells. Oncogene, 10, 1855-1864 (1995).
29. JOHN, S., REEVES, R.B., LIN, J.X., CHILD, R., LEIDEN, J.M., THOMPSON, C.B. and LEONARD, W.J., Regulation of cell-type-specific interleukin-2 receptor alpha chain gene expression: potential role of physical interactions between Elfl, HMGI(Y). and NFkappaB family proteins. Mol. cell. Biol., 15, 1786-1796 (1995).
30. JOHNSON, J.P., DEMMER-DIECKMANN, M., MEO, T., HADAM, M.R. and REITHMULLER, G., Surface antigens of human melanoma cells defined by monoclonal antibodies I. Biochemical characterization of two antigens found on cell lines and fresh tumors of diverse tissue origin. Europ. J. Immunol., 11, 825-831 (1981).
31. KOZLOWSKI, J.M., FIDLER, I.J., CAMPBELL, D., Xu, Z., KAIGHN, M.E. and HART, I.R., Metastaiic behavior of human tumor cell lines grown in the nude mouse. Cancer Res., 44, 3522-3529 (1984).
32. LEE, J.-H., MIRLE, M.E., HICKS, D.J., PHILLIPS, K.K., TRENT, J.M., WEISSMAN, B.E. and WELCH, D.R. KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. J. nat. Cancer Inst., 88, 1731-1737 (1996).
33. LEE, S.W., TOMASETTO, C. and SAGER, R., Positive selection of candidate tumor-suppressor genes by subtractive hybridization. Proc. nat. Acad. Sci. (Wash.), 88, 2825-2829 (1991).
34. LEWIS, H., KASZUBSKA, W., DELAMARTER, J.F. and WHELAN, J. Cooperativity between two NF-kappaB complexes, mediated by high-mobility-group protein I(Y). is essential for cytokine-induced expression of the E-selectin promoter. Mol. cell. Biol., 14, 5701-5709 (1994).
35. 3H1 cells by subtractive hybridization. Biotechniques, 16, 722-729 (1994).
36. LI, X.Z., MCNEILAGE, L.J. and WHITTINGHAM, S., The nucleotide sequence of a human cDNA encoding the highly conserved nucleolar phosphoprotein B23. Biochem. biophys. Res. Comm., 163, 72-78 (1989).
37. LIANG, P., AVERBOUKH, L. and PARDEE, A.B., Distribution and cloning of eukaryotic mRNAs by means of differential display: refinements and optimization. Nucleic Acids Res., 21, 3269-3275 (1993).
38. LIANG, P. and PARDEE, A.B., Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science. 257, 967-971 (1992).
39. MIELE, M.E., ROBERTSON, G., LEE, J.H., COLEMAN, A., MCGARY, C.T., FISHER, PB., LUGO, T.G. and WELCH, D.R., Metastasis suppressed, but tumorigenicity and local invasiveness unaffected, in the human melanoma cell line MelJuSo after introduction of human chromosomes 1 or 6. Mol. Carcinogenesis, 15, 284-299 (1996).
40. MITCHELL, P.J., TiMMONS, P.M., HEBERT, J.M., RiGBY, P.W. and TJIAN, R., Transcription factor AP2 is expressed in neural crest cell lineages during mouse embryogenesis. Genes Develop., 5, 105-119 (1991).
41. MUELLER, B.M., REISFELD, R.A., EDGINGTON, T.S. und RUG, W., Expression of tissue factor by melanoma cell promotes efficient hematogenous metastasis. Proc. nat. Acad. Sci. (Wash.), 89, 11832-11836 (1992).
42. NOONAN, K.E., BECK, C., HOLZMAYER, T.A., CHIN, J., WUNDER, J.S., ANDRULIS, I.L., GAZDAR, A.F., WILLMAN, C.L., GRIFFITH, B., VON HOFF, D. and RONINSON, I.B. Quantitative analysis of MDR1 (multidmg resistance) gene expression in human tumors by polymerase chain reaction. Proc. nat. Acad. Sci. (Wash.), 87, 7160-7164 (1990).
43. PARRY, R.L., CHIN, T., EPSTEIN, J., HUDSON, P.L., POWELL, D.M. and DONAHOE., P.K., Recombinant human Mullerian inhibiting substance inhibits human ocular melanoma cell lines in vitro and in vivo. Cancer Res., 52, 1182-1186 (1992).
44. PHILLIPS, S.M., BENDALL, A.J. and RAMSHAW, I.A., Isolation of gene associated with high metastatic potential in rat mammary adenocarcinomas. J. nat. Cancer Inst., 82, 199-203 (1990).
45. RAM, T.G., REEVES, R. and HOSICK, H.L., Elevated high mobility group I(Y) acne expression is associated with progressive transformation of mouse mammary epithelial cells. Cancer Res., 53, 2655-2660 (1993).
46. SANFORD, J.A. and STUBBLEFIELD, E., General protocol for microcellmediated chromosome transfer. Somatic Cell Mol. Genet., 13, 279-284 (1987).
47. SAXON, P.J. and STANBRIDGE, E.J., Transfer and selective retention of single specific human chromosomes via microcell-mediated chromosome transfer, Meth. Enzymol., 151, 313-325 (1987).
48. SNAPE, A.M., WINNING, R.S. and SARGENT, T.D., Transcription factor AP2 is tissue-specific in Xenopus and is closely related or identical to keratin transcription factor 1 (KTF1). Development. 113, 283-293 (1991).
49. STEEG, P.S., BEVILACQUA, G., KOPPER, L., THORGEIRSSON, U.P. TALMADGE, J.E., LIOTTA, L.A. and SOBEL, M.E., Evidence for a novel gene associated with low tumor metastatic potential. J. nat. Cancer Inst., 80, 200-204 (1988).
50. TAKAHASHI, Y., BUCANA, C.D., LIU, W.B., YONEDA, J., KITADAI, Y., CLEARY, K.R. and ELLIS, L.M., Platelet-derived endothelial cell growth factor in human colon cancer angiogenesis: role of infiltrating cells. J. nat. Cancer Inst., 88, 1146-1151 (1996).
51. TAMIMI, Y., VAN DER POEL, H.G., DENYN, M.-M., UMBAS, R., KARTHAUS, H.F.M., DEBRUYNE, F.M.J. and SCHALKEN, J.A., Increased expression of high mobility group protein I(Y) in high grade prostatic cancer determined by in situ hybridization. Cancer Res. 53, 5512-5516 (1993).
52. TOH, Y., PENCIL, S.D. and NICOLSON, G.L., A novel candidate metastasisassociated gene, mtal, differentially expressed in highly metastatic mammary adenocarcinoma cell lines. cDNA cloning, expression, and protein analyses. J. biol. Chem., 269, 22958-22963 (1994).
53. VALYI-NAGY, I., SHIH, I.-M., GYORFI, T., GREENSTEIN, D., JUHASZ, I., ELDER, D.E. and HERLYN, M., Spontaneous and induced differentiation of human melanoma cells. Int. J. Cancer, 54, 159-165 (1993).
54. WELCH, D.R., Technical considerations for studying cancer metastasis in vivo. Clin. exp. Metastasis. 15, 272-306 (1997).
55. WELCH, D.R., BISI, J.E., MILLER, B.E., CONAWAY, D., SEFTOR, E.A., YOHEM, K.H., GILMORE, L.B., SEFTOR, R.E.B., NAKAJIMA, M. and HENDRIX, M.J.C., Characterization of a highly invasive and spontaneously metastatic human malignant melanoma cell line. Int. J. Cancer, 47, 227-237 (1991).
56. WELCH, D.R., CHEN, P., MIELE, M.E., MCGARY, C.T., BOWER, J.M., WEISSMAN, B.E. and STANBRIDGE, E.J., Microcell-mediated transfer of chromosome 6 into metastatic human C8161 melanoma cells suppresses metastasis but does not inhibit tumorigenicity. Oncogene, 9, 255-262 (1994).
57. mda6/WF1 a suppressor malignant melanoma metastasis? Mol. cell. Differentiation, 4, 91-111 (1996).
58. WILLIAMS, T., APMON, A., LUSCHER, B. and TJIAN, R., Cloning and expression of AP2, a cell-type-specific transcription factor that activates inducible enhancer elements. Genes Develop., 2, 1557-1569 (1988).
59. WAF1/CIP1 expression. Nature (Genet.), 15, 78-82 (1997).